Verge Genomics' ALS Drug Fails Amid Shift to Partner Model
Verge Genomics' only clinical-stage ALS drug has failed, prompting the company to shift its focus to a partnership model for its AI-driven discovery platform.
Tag
Verge Genomics
All articles tagged with #verge genomics
Verge Genomics and AstraZeneca Join Forces in $42M Drug Discovery Partnership
Verge Genomics has entered into a four-year, $882 million deal with AstraZeneca's rare disease division, Alexion, focusing on undisclosed rare neurodegenerative and neuromuscular diseases. As part of the deal, AstraZeneca will pay Verge $42 million upfront, including equity and near-term payments, and will also take an equity stake in Verge.